YARW (Yarrow Bioscience) OCF Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

YARW Yarrow Bioscience Inc YARW
8 GF Score
Price $32.99
View Full Analysis

What is Yarrow Bioscience OCF Margin %?

Yarrow Bioscience YARW +8.34% 8 OCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates YARW with a GF Score™ of 8/100.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Yarrow Bioscience's Cash Flow from Operations for the six months ended in Dec. 2025 was $0.00 Mil. Yarrow Bioscience's Revenue for the six months ended in Dec. 2025 was $0.00 Mil. Therefore, Yarrow Bioscience's OCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Yarrow Bioscience's current OCF Yield % is 0.00%.

The historical rank and industry rank for Yarrow Bioscience's OCF Margin % or its related term are showing as below:


YARW's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -68.59
* Ranked among companies with meaningful OCF Margin % only.

Yarrow Bioscience OCF Margin % Related Terms

Yarrow Bioscience OCF Margin % Historical Data

* Premium members only.

The historical data trend for Yarrow Bioscience's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yarrow Bioscience OCF Margin % Chart

Yarrow Bioscience Annual Data
Trend Dec25
OCF Margin %
0.00

Yarrow Bioscience Semi-Annual Data
Dec25
OCF Margin % 0.00
YARW
8GF Score
Yarrow Bioscience Inc YARW
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Yarrow Bioscience OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Yarrow Bioscience's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=0/0
= %

Yarrow Bioscience's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Yarrow Bioscience (YARW) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Yarrow Bioscience and its competitors.
Is Yarrow Bioscience's OCF Margin % too high?
Yarrow Bioscience's current OCF Margin % is 0.00%. Overall, Yarrow Bioscience has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Yarrow Bioscience's OCF Margin % compare to ?
Yarrow Bioscience's OCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Yarrow Bioscience and its competitors. Yarrow Bioscience's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yarrow Bioscience stock overvalued right now?
Yarrow Bioscience (YARW) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Yarrow Bioscience's overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Yarrow Bioscience (YARW), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Yarrow Bioscience Business Description

Comparable Companies
Address 251 Little Falls Drive, County of New Castle, City of Wilmington, DE, USA, 19808
Yarrow Bioscience Inc is a clinical-stage biopharmaceutical company focused on developing biotherapeutics for autoimmune thyroid diseases. Its flagship product candidate, YB-101 (also known as GenSci098), is a humanized, monoclonal antibody targeting the thyroid-stimulating hormone receptor, which Yarrow plans to develop for the treatment of Graves' disease (GD) and potentially thyroid eye disease (TED). The company has one reportable segment relating to the research and development of its research programs, GD and TED.
8GF Score

Get the complete analysis for YARW

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$32.99
Price